What did @trimexplainspeps actually say?
The creator pitched a "perfect peptide stack" for hair regrowth, naming three compounds: GHK-Cu, Biotinoyl Tripeptide-1, and AHK-Cu. The claims ranged from GHK-Cu "reducing DHT on the scalp" to AHK-Cu "allowing new blood vessels to form at the root." The video closes with a confident declaration: "There is no reason to be balding in 2026."
That last line is marketing, not medicine. But buried inside the hype are some claims that do have legitimate scientific backing, and some that are either overstated or just not supported by human clinical data. It's worth separating the two, because the peptide-for-hair space has real research behind it, alongside a lot of wishful thinking.
Does the science back this up?
Partially, yes. GHK-Cu has the most evidence, though most of it is in vitro or animal-based. The DHT-reduction claim is the weakest of the bunch.
GHK-Cu (copper peptide glycyl-L-histidyl-L-lysine) has been studied for wound healing and skin remodeling for decades. Regarding hair specifically, Pickart et al. (2015, Journal of Aging Science) documented GHK-Cu's role in stimulating follicle proliferation and reducing inflammatory cytokines in scalp tissue. A 2018 study by Sadgrove et al. in Cosmetics noted improved follicle cycling in animal models. However, robust randomized controlled trials in humans are scarce.
Biotinoyl Tripeptide-1 (the "biotinal tripeptide one" referenced in the video) is a cosmetic peptide used in commercial hair serums. A study by Loing et al. (2013, Journal of Cosmetic Science) found improved hair anchoring strength and reduced hair loss in a small clinical trial. That's real, if limited, data.
AHK-Cu is the least studied of the three. The angiogenesis claim (new blood vessel formation) comes largely from copper peptide research broadly, not AHK-Cu specifically in hair tissue. Extrapolating from general copper peptide biology to this specific compound in follicle growth is a stretch.
What did they get wrong (or right)?
The DHT claim is the biggest problem. GHK-Cu does not have strong clinical evidence for reducing scalp DHT levels. That's a mechanism associated with finasteride (a 5-alpha reductase inhibitor) and, to a lesser extent, topical minoxidil's indirect effects. Conflating anti-inflammatory activity with DHT suppression misleads viewers who may be choosing between proven treatments and peptide serums.
The creator also says GHK-Cu works "especially in collagen," which is garbled phrasing. GHK-Cu does upregulate collagen synthesis, and that does benefit the dermal papilla environment. So the underlying biology is real, even if the sentence structure makes it sound like GHK-Cu is an ingredient in collagen rather than a stimulator of it.
On the other hand, the claim that Biotinoyl Tripeptide-1 improves "hair anchoring" is grounded in Loing et al.'s work. Credit where it's due. The eyebrow and eyelash density mention also has some cosmetic-industry research support, though it's largely proprietary data from ingredient suppliers, which should make anyone skeptical.
The AHK-Cu section is the most speculative. Extending the anagen (growth) phase and promoting angiogenesis are plausible mechanisms based on copper peptide biology, but applying that to AHK-Cu specifically in scalp tissue is a leap the published literature doesn't fully support yet.
What should you actually know?
These peptides are not FDA-approved treatments for androgenetic alopecia or any other hair loss condition. The two treatments with the most clinical evidence for hair loss remain topical minoxidil and oral or topical finasteride. If you are experiencing significant hair loss, those are the evidence-based starting points, ideally under the supervision of a licensed provider.
That doesn't mean these peptides are useless. GHK-Cu in particular has a legitimate body of preclinical research, and several cosmetic formulations have shown modest benefit in small trials. They may work as adjuncts. "May work as an adjunct in a cosmetic formulation" is a very different claim from "there is no reason to be balding in 2026."
Peptides used topically in cosmetic products are different from pharmaceutical-grade peptides used in compounded formulations. Delivery method, concentration, and formulation stability all affect efficacy. The video does not address any of this, and viewers cannot make informed decisions without it.
If you are curious about peptide-based hair treatments, talk to a telehealth provider or dermatologist who can evaluate your specific type of hair loss, because not all hair loss has the same cause, and a stack that targets follicle cycling will not fix traction alopecia or a nutritional deficiency.